Literature DB >> 8223857

Somatic diversification and affinity maturation of IgM and IgG anti-DNA antibodies in murine lupus.

S Hirose1, M Wakiya, Y Kawano-Nishi, J Yi, R Sanokawa, S Taki, T Shimamura, T Kishimoto, H Tsurui, H Nishimura.   

Abstract

Molecular events occurring during the process of generation of pathogenic immunoglobulin (Ig)G anti-DNA antibodies in systemic lupus erythematosus (SLE) were studied using a newly established method. We analyzed the Ig variable (V) region gene sequence and DNA-binding activity of IgM and IgG anti-DNA monoclonal antibodies (mAb) from individual SLE-prone (NZB x NZW) F1 mice. The first event appeared to be clonal selection and expansion of IgM anti-DNA clones, in which several clones had intraclonal V gene mutations. Although the number of mutations was small, the mutated IgM clones were associated with an increase in DNA-binding activity. The somatic mutations located in complementarity-determining regions (CDR) and in framework regions (FR) of V genes were apparently related to changes in DNA-binding activity. IgG anti-DNA clones that progressively increased in number with aging had numerous somatic mutations in the V region genes and there was a pair of clones which showed an intraclonal accumulation of mutations, in association with increase in the DNA-binding activity. All these findings show that somatic mutations associated with affinity maturation of the V region begin immediately before isotype-switching from IgM to IgG of the clones that have been selected and expanded, in an antigen-driven manner and/or by other forces. We propose that further accumulations of intraclonal somatic hypermutation, in association with selection and expansion of high affinity IgG clones, may lead to formation of highly pathogenic anti-DNA antibodies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8223857     DOI: 10.1002/eji.1830231114

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

Review 1.  Isotype-dependent pathogenicity of autoantibodies: analysis in experimental autoimmune hemolytic anemia.

Authors:  S Izui; L Fossati-Jimack; S A da Silveira; T Moll
Journal:  Springer Semin Immunopathol       Date:  2001-12

Review 2.  Significance of MHC class II haplotypes and IgG Fc receptors in SLE.

Authors:  Sachiko Hirose; Yi Jiang; Hiroyuki Nishimura; Toshikazu Shirai
Journal:  Springer Semin Immunopathol       Date:  2006-09-14

3.  B1 lymphocytes and myeloid dendritic cells in lymphoid organs are preferential extratumoral sites of parvovirus minute virus of mice prototype strain expression.

Authors:  Zahari Raykov; Larissa Savelyeva; Ginette Balboni; Thomas Giese; Jean Rommelaere; Nathalia A Giese
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  A novel approach for detecting an immunodominant antigen of Porphyromonas gingivalis in diagnosis of adult periodontitis.

Authors:  T Kawai; H O Ito; N Sakato; H Okada
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

5.  AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4.

Authors:  Clayton A White; J Seth Hawkins; Egest J Pone; Elliot S Yu; Ahmed Al-Qahtani; Thach Mai; Hong Zan; Paolo Casali
Journal:  Autoimmunity       Date:  2011-05-18       Impact factor: 2.815

6.  Co-existence of somatic hypermutation and gene conversion in hypervariable regions of single Igkappa clones.

Authors:  J Liu; B Wolf
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

7.  Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA.

Authors:  G S Gilkeson; A M Pippen; D S Pisetsky
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

8.  High pathogenic potential of low-affinity autoantibodies in experimental autoimmune hemolytic anemia.

Authors:  L Fossati-Jimack; L Reininger; Y Chicheportiche; R Clynes; J V Ravetch; T Honjo; S Izui
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.